In recent news, Deloitte has acquired CasePointer, a disease surveillance business that was founded in 2008 as open source software to help public health agencies work with epidemiological data. This acquisition supports Deloitte’s growth in the field of public health transformation.
CasePointer’s tools include the EpiTrax platform for managing data on diseases and health hazards, which Deloitte plans to integrate with its GovConnect digital assets. With this integration, Deloitte’s team of technologists and public health specialists will collaborate with clients to address their modernization and surveillance needs.
This acquisition follows Deloitte’s purchase of Gryphon Scientific in April, another public health-focused company specializing in using artificial intelligence and data to respond to infectious diseases. Jason Salzetti, leader of Deloitte’s government and public services practice, emphasized that the acquisition of CasePointer aligns with the firm’s investments and supports its expansion into new markets.
One notable investment from Deloitte is the development of generative artificial intelligence tools for health and human services agencies, first announced in September 2023. These tools aim to assist state and local government clients in improving the delivery of benefits and services to citizens.
